167 related articles for article (PubMed ID: 32043328)
1. Autologous Hematological Stem Cell Transplantation for Systemic Sclerosis in Israel.
Rimar D; Butbul Aviel Y; Gefen A; Nevo N; Shen-Orr SS; Starosvetsky E; Rosner I; Rozenbaum M; Kaly L; Boulman N; Slobodin G; Zuckerman T
Isr Med Assoc J; 2020 Feb; 22(2):104-110. PubMed ID: 32043328
[TBL] [Abstract][Full Text] [Related]
2. Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial.
Burt RK; Shah SJ; Dill K; Grant T; Gheorghiade M; Schroeder J; Craig R; Hirano I; Marshall K; Ruderman E; Jovanovic B; Milanetti F; Jain S; Boyce K; Morgan A; Carr J; Barr W
Lancet; 2011 Aug; 378(9790):498-506. PubMed ID: 21777972
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of autologous haematopoietic stem cell transplantation in systemic sclerosis: a systematic review of the literature.
Eyraud A; Scouppe L; Barnetche T; Forcade E; Lazaro E; Duffau P; Richez C; Seneschal J; Truchetet ME;
Br J Dermatol; 2018 Mar; 178(3):650-658. PubMed ID: 28906550
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic stem cell transplantation for systemic sclerosis: Brazilian experience.
Henrique-Neto Á; Vasconcelos MYK; Dias JBE; de Moraes DA; Gonçalves MS; Zanin-Silva DC; Zucoloto TG; de Oliveira MFC; Dotoli GM; Weffort LF; Leopoldo VC; Oliveira MC
Adv Rheumatol; 2021 Feb; 61(1):9. PubMed ID: 33549135
[TBL] [Abstract][Full Text] [Related]
5. Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysis.
Burt RK; Oliveira MC; Shah SJ; Moraes DA; Simoes B; Gheorghiade M; Schroeder J; Ruderman E; Farge D; Chai ZJ; Marjanovic Z; Jain S; Morgan A; Milanetti F; Han X; Jovanovic B; Helenowski IB; Voltarelli J
Lancet; 2013 Mar; 381(9872):1116-24. PubMed ID: 23363664
[TBL] [Abstract][Full Text] [Related]
6. Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease.
Binks M; Passweg JR; Furst D; McSweeney P; Sullivan K; Besenthal C; Finke J; Peter HH; van Laar J; Breedveld FC; Fibbe WE; Farge D; Gluckman E; Locatelli F; Martini A; van den Hoogen F; van de Putte L; Schattenberg AV; Arnold R; Bacon PA; Emery P; Espigado I; Hertenstein B; Hiepe F; Kashyap A; Kötter I; Marmont A; Martinez A; Pascual MJ; Gratwohl A; Prentice HG; Black C; Tyndall A
Ann Rheum Dis; 2001 Jun; 60(6):577-84. PubMed ID: 11350846
[TBL] [Abstract][Full Text] [Related]
7. CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I/II clinical trial conducted in Japan.
Ayano M; Tsukamoto H; Mitoma H; Kimoto Y; Akahoshi M; Arinobu Y; Miyamoto T; Horiuchi T; Niiro H; Nagafuji K; Harada M; Akashi K
Arthritis Res Ther; 2019 Jan; 21(1):30. PubMed ID: 30670057
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors for treatment-related mortality and major adverse events after autologous haematopoietic stem cell transplantation for systemic sclerosis: results of a long-term follow-up multicentre study.
van Bijnen S; de Vries-Bouwstra J; van den Ende CH; Boonstra M; Kroft L; Geurts B; Snoeren M; Schouffoer A; Spierings J; van Laar JM; Huizinga TW; Voskuyl A; Marijt E; van der Velden W; van den Hoogen FH; Vonk MC
Ann Rheum Dis; 2020 Aug; 79(8):1084-1089. PubMed ID: 32409324
[TBL] [Abstract][Full Text] [Related]
9. Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis: A Systematic Review and Meta-Analysis.
Shouval R; Furie N; Raanani P; Nagler A; Gafter-Gvili A
Biol Blood Marrow Transplant; 2018 May; 24(5):937-944. PubMed ID: 29374527
[TBL] [Abstract][Full Text] [Related]
10. High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study.
Nash RA; McSweeney PA; Crofford LJ; Abidi M; Chen CS; Godwin JD; Gooley TA; Holmberg L; Henstorf G; LeMaistre CF; Mayes MD; McDonagh KT; McLaughlin B; Molitor JA; Nelson JL; Shulman H; Storb R; Viganego F; Wener MH; Seibold JR; Sullivan KM; Furst DE
Blood; 2007 Aug; 110(4):1388-96. PubMed ID: 17452515
[TBL] [Abstract][Full Text] [Related]
11. Clinical and Molecular Findings After Autologous Stem Cell Transplantation or Cyclophosphamide for Scleroderma: Handling Missing Longitudinal Data.
Keyes-Elstein L; Pinckney A; Goldmuntz E; Welch B; Franks JM; Martyanov V; Wood TA; Crofford L; Mayes M; McSweeney P; Nash R; Georges G; Csuka ME; Simms R; Furst D; Khanna D; Clair EWS; Whitfield ML; Sullivan KM
Arthritis Care Res (Hoboken); 2023 Feb; 75(2):307-316. PubMed ID: 34533286
[TBL] [Abstract][Full Text] [Related]
12. [Autologous stem cell transplantation in systemic sclerosis].
Henes JC; Wirths S; Kötter I
Z Rheumatol; 2016 Oct; 75(8):762-769. PubMed ID: 27510996
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive Therapy After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients-High Efficacy of Rituximab.
Gernert M; Tony HP; Fröhlich M; Schwaneck EC; Schmalzing M
Front Immunol; 2021; 12():817893. PubMed ID: 35111167
[TBL] [Abstract][Full Text] [Related]
14. Autologous haematopoietic stem cell transplantation for Japanese patients with systemic sclerosis: Long-term follow-up on a phase II trial and treatment-related fatal cardiomyopathy.
Nakamura H; Odani T; Yasuda S; Noguchi A; Fujieda Y; Kato M; Oku K; Bohgaki T; Sugita J; Endo T; Teshima T; Atsumi T
Mod Rheumatol; 2018 Sep; 28(5):879-884. PubMed ID: 29251023
[TBL] [Abstract][Full Text] [Related]
15. Stem cell transplant in systemic sclerosis: An Indian experience.
Nair V; Vasdev V; Kumar A; Shankar S; Nair V; Sharma A
Int J Rheum Dis; 2018 Apr; 21(4):859-865. PubMed ID: 29392863
[TBL] [Abstract][Full Text] [Related]
16. High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes.
McSweeney PA; Nash RA; Sullivan KM; Storek J; Crofford LJ; Dansey R; Mayes MD; McDonagh KT; Nelson JL; Gooley TA; Holmberg LA; Chen CS; Wener MH; Ryan K; Sunderhaus J; Russell K; Rambharose J; Storb R; Furst DE
Blood; 2002 Sep; 100(5):1602-10. PubMed ID: 12176878
[TBL] [Abstract][Full Text] [Related]
17. Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.
Sullivan KM; Goldmuntz EA; Keyes-Elstein L; McSweeney PA; Pinckney A; Welch B; Mayes MD; Nash RA; Crofford LJ; Eggleston B; Castina S; Griffith LM; Goldstein JS; Wallace D; Craciunescu O; Khanna D; Folz RJ; Goldin J; St Clair EW; Seibold JR; Phillips K; Mineishi S; Simms RW; Ballen K; Wener MH; Georges GE; Heimfeld S; Hosing C; Forman S; Kafaja S; Silver RM; Griffing L; Storek J; LeClercq S; Brasington R; Csuka ME; Bredeson C; Keever-Taylor C; Domsic RT; Kahaleh MB; Medsger T; Furst DE;
N Engl J Med; 2018 Jan; 378(1):35-47. PubMed ID: 29298160
[TBL] [Abstract][Full Text] [Related]
18. Association of Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis With Marked Improvement in Health-Related Quality of Life.
Maltez N; Puyade M; Wang M; Lansiaux P; Marjanovic Z; Charles C; Steele R; Baron M; Colmegna I; Hudson M; Farge D;
Arthritis Rheumatol; 2021 Feb; 73(2):305-314. PubMed ID: 32909693
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic stem cell transplantation for systemic sclerosis: history and current status.
Burt RK; Milanetti F
Curr Opin Rheumatol; 2011 Nov; 23(6):519-29. PubMed ID: 21857226
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic stem cell transplantation for systemic sclerosis with rapid improvement in skin scores: is neoangiogenesis occurring?
Burt RK; Oyama Y; Traynor A; Quigley K; Brush M; Rodriguez J; Barr WG
Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S65-7. PubMed ID: 12931246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
